SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - Nature

Indonesia Berita Berita

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - Nature
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Nature
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 68%

Nature research paper: SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo

Emergence of SARS-CoV-2 variants of concern with progressively increased transmissibility between humans is a threat to global public health. The omicron variant also evades immunity from natural infection or vaccines, but it is unclear whether its exceptional transmissibility is due to immune evasion or intrinsic virological properties.

Kenrie P. Y. Hui, John C. W. Ho, Man-chun Cheung, Ka-chun Ng, Rachel H. H. Ching, Ka-ling Lai, Tonia Tong Kam, Haogao Gu, Leo L. M. Poon, Malik Peiris & Michael C. W. ChanKenrie P. Y. Hui, Leo L. M. Poon, Malik Peiris & Michael C. W. Chan Division of Cardiothoracic Surgery, Department of Surgery, Queen Mary Hospital, Pokfulam, Hong Kong SAR, ChinaDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Nature /  🏆 64. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

T cell responses to SARS-CoV-2 spike cross-recognize Omicron - NatureNature - T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Baca lebih lajut »

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - NatureNature research paper: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Baca lebih lajut »

Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron - NatureNature - Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
Baca lebih lajut »

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipientsInfection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipientsA third dose of mRNA vaccine may be necessary to protect recipients of organ transplants from COVID19 and produce effective antibody responses against SARSCoV2, suggests a new immunological analysis of kidney transplant recipients. ScienceTM
Baca lebih lajut »

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - NatureNature research paper: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Baca lebih lajut »



Render Time: 2025-04-15 23:56:14